Join us in the weekend of the 4th & 5th of June 2022 for the international symposium on the topic of ‘The Leiden Headache Center into a new era’.
This symposium provides an overview of the latest findings and treatment options in the field of headaches and migraines which can be applied in clinical practice.
International top experts and researchers
The Leiden Headache Center with international top experts, will take the audience on a journey through trendsetting research, treatment options for migraine and other headaches. They will discuss questions such as: what are monoclonal CGRP antibodies? What is chronic migraine and what about medication overuse? Are headaches different in women than in men and which types of secondary headaches can be treated well?
Topics
The program will contain the following topics:
- Mechanisms of migraine
- Biomarkers
- CGRP- clinic
- Towards new targets
- Gender aspects of Headache
- Other headaches
Intended audience
(inter)National neurologists or residents-in-neurology, reseachers including Phd-students in the field of headache, physician assistants, nurse practitioners and other healthcare providers with interest in headache.
Register now: Leiden Headache Center into a new era – Boerhaave Continuing Medical Education (CME)
Download program: https://www.boerhaavecontinuingmedicaleducation.com/media/3003/63535-leiden-headache-center-a-new-era-4-5-june-2022-draft-programme.pdf
Organising committee
Gisela Terwindt and Arn van den Maagdenberg
‘Leiden Headache Center into a new era’ is sponsored by Lilly, Lundbeck, Novartis and Teva.